Our data indicate that PRP4 may decrease the production of melanin in B16F10 cells by downregulating AC–cAMP–MITF–tyrosinase signaling pathway, which subsequently leads to the promotion of skin cancer. This evidence concerns the gene TYR and skin neoplasm.